80 related articles for article (PubMed ID: 14519679)
1. Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes.
Stallmann HP; Faber C; Slotema ET; Lyaruu DM; Bronckers AL; Amerongen AV; Wuisman PI
J Antimicrob Chemother; 2003 Nov; 52(5):853-5. PubMed ID: 14519679
[TBL] [Abstract][Full Text] [Related]
2. In vivo release of the antimicrobial peptide hLF1-11 from calcium phosphate cement.
Stallmann HP; de Roo R; Faber C; Amerongen AV; Wuisman PI
J Orthop Res; 2008 Apr; 26(4):531-8. PubMed ID: 17972323
[TBL] [Abstract][Full Text] [Related]
3. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
Faber C; Stallmann HP; Lyaruu DM; Joosten U; von Eiff C; van Nieuw Amerongen A; Wuisman PI
Antimicrob Agents Chemother; 2005 Jun; 49(6):2438-44. PubMed ID: 15917544
[TBL] [Abstract][Full Text] [Related]
4. In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile.
Stallmann HP; Faber C; Bronckers AL; Nieuw Amerongen AV; Wuisman PI
BMC Musculoskelet Disord; 2006 Feb; 7():18. PubMed ID: 16504140
[TBL] [Abstract][Full Text] [Related]
5. Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement.
Stallmann HP; Faber C; Bronckers AL; Nieuw Amerongen AV; Wuisman PI
J Antimicrob Chemother; 2004 Aug; 54(2):472-6. PubMed ID: 15231767
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hLF1-11 immobilization onto chitosan ultrathin films, and its effects on antimicrobial activity.
Costa F; Maia S; Gomes J; Gomes P; Martins MC
Acta Biomater; 2014 Aug; 10(8):3513-21. PubMed ID: 24631659
[TBL] [Abstract][Full Text] [Related]
7. Histatin and lactoferrin derived peptides: antimicrobial properties and effects on mammalian cells.
Stallmann HP; Faber C; Bronckers AL; de Blieck-Hogervorst JM; Brouwer CP; Amerongen AV; Wuisman PI
Peptides; 2005 Dec; 26(12):2355-9. PubMed ID: 15979203
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans.
Huo L; Zhang K; Ling J; Peng Z; Huang X; Liu H; Gu L
Arch Oral Biol; 2011 Sep; 56(9):869-76. PubMed ID: 21382611
[TBL] [Abstract][Full Text] [Related]
9. The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response.
van der Does AM; Bogaards SJ; Jonk L; Wulferink M; Velders MP; Nibbering PH
Biometals; 2010 Jun; 23(3):493-505. PubMed ID: 20238236
[TBL] [Abstract][Full Text] [Related]
10. Covalent immobilization of hLf1-11 peptide on a titanium surface reduces bacterial adhesion and biofilm formation.
Godoy-Gallardo M; Mas-Moruno C; Fernández-Calderón MC; Pérez-Giraldo C; Manero JM; Albericio F; Gil FJ; Rodríguez D
Acta Biomater; 2014 Aug; 10(8):3522-34. PubMed ID: 24704699
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections.
Kazemzadeh-Narbat M; Kindrachuk J; Duan K; Jenssen H; Hancock RE; Wang R
Biomaterials; 2010 Dec; 31(36):9519-26. PubMed ID: 20970848
[TBL] [Abstract][Full Text] [Related]
12. Bone substitute materials delivering zoledronic acid: physicochemical characterization, drug load, and release properties.
Sörensen TC; Arnoldi J; Procter P; Robioneck B; Steckel H
J Biomater Appl; 2013 Feb; 27(6):727-38. PubMed ID: 22090432
[TBL] [Abstract][Full Text] [Related]
13. Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus.
Bai X; Teng D; Tian Z; Zhu Y; Yang Y; Wang J
Biometals; 2010 Jun; 23(3):431-9. PubMed ID: 20145976
[TBL] [Abstract][Full Text] [Related]
14. Controlling the biological function of calcium phosphate bone substitutes with drugs.
Verron E; Bouler JM; Guicheux J
Acta Biomater; 2012 Oct; 8(10):3541-51. PubMed ID: 22729019
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment.
Dion A; Langman M; Hall G; Filiaggi M
Biomaterials; 2005 Dec; 26(35):7276-85. PubMed ID: 16024076
[TBL] [Abstract][Full Text] [Related]
16. Of the in vivo behavior of calcium phosphate cements and glasses as bone substitutes.
Sanzana ES; Navarro M; Macule F; Suso S; Planell JA; Ginebra MP
Acta Biomater; 2008 Nov; 4(6):1924-33. PubMed ID: 18539102
[TBL] [Abstract][Full Text] [Related]
17. Silver-doped calcium phosphate cements with antimicrobial activity.
Ewald A; Hösel D; Patel S; Grover LM; Barralet JE; Gbureck U
Acta Biomater; 2011 Nov; 7(11):4064-70. PubMed ID: 21763795
[TBL] [Abstract][Full Text] [Related]
18. Calcium phosphate cements as bone drug delivery systems: a review.
Ginebra MP; Traykova T; Planell JA
J Control Release; 2006 Jun; 113(2):102-10. PubMed ID: 16740332
[TBL] [Abstract][Full Text] [Related]
19. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity.
van der Does AM; Hensbergen PJ; Bogaards SJ; Cansoy M; Deelder AM; van Leeuwen HC; Drijfhout JW; van Dissel JT; Nibbering PH
J Immunol; 2012 May; 188(10):5012-9. PubMed ID: 22523385
[TBL] [Abstract][Full Text] [Related]
20. Development of a biodegradable antibiotic delivery system.
Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH
Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
